CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award | +31,000 | 224,024 | ||
| 2026-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +126,000 | 126,000 | ||
| 2025-12-17 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −9,983 | $22.16 | $221K | 193,024 |
| 2025-12-16 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −11,225 | $21.88 | $246K | 203,007 |
| 2025-11-07 | Jarrett Jennifer Chief Operating Officer | Option exercise 10b5-1 | +50,291 | $1.23 | $62K | 264,523 |
| 2025-11-07 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −50,291 | $18.97 | $954K | 214,232 |
| 2025-11-07 | Jarrett Jennifer Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,291 | $1.23 | $62K | 80,583 |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Option exercise 10b5-1 | +37,792 | $1.23 | $46K | 252,024 |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −37,792 | $15.05 | $569K | 214,232 |
| 2025-10-08 | Jarrett Jennifer Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,792 | 130,874 | ||
| 2025-10-06 | Jarrett Jennifer Chief Operating Officer | Option exercise 10b5-1 | +12,500 | $1.23 | $15K | 226,732 |
| 2025-10-06 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −12,500 | $14.54 | $182K | 214,232 |
| 2025-10-06 | Jarrett Jennifer Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 168,666 | ||
| 2025-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award | +50,000 | 213,369 | ||
| 2025-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-12-15 | Jarrett Jennifer Chief Operating Officer | Shares withheld for taxes | −27,501 | $16.08 | $442K | 163,369 |
| 2024-09-15 | Jarrett Jennifer Chief Operating Officer | Shares withheld for taxes | −12,670 | $17.95 | $227K | 190,394 |
| 2024-06-15 | Jarrett Jennifer Chief Operating Officer | Shares withheld for taxes | −12,670 | $16.97 | $215K | 203,064 |
| 2024-03-27 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −11,551 | $17.55 | $203K | 215,253 |
| 2024-03-18 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −12,153 | $17.84 | $217K | 228,100 |
Page 1 of 4 · 67 trades